BIH Center for Regenerative Therapies

News | 06 December 2022

Scientists from the Berlin Institute of Health at Charité (BIH), together with colleagues from Germany and the UK, have found that a commonly used liver drug also affects infection with the SARS-CoV-2…

News | 22 November 2022

Anomalies in the formation of blood and lymphatic vessels are, thankfully, rare. Those who do have them face a lifetime of complications that can range from the mild to the life-threatening. To date,…

News | 05 September 2022

In August 2022 the first round of the ad-hoc Booster Grant was organized by BIH Center for Regenerative Therapies (BCRT). Aim of the call was to provide scientists in the BIH-Charité network with a…

News | 08 June 2022

Effective July 1, 2022, Ludovic Vallier will take up the W3 Einstein Strategic Professorship for Stem Cells in Regenerative Therapies at the Berlin Institute of Health at Charité (BIH). Vallier is an…

News | 14 January 2021

Press release by Charité and the Berlin Institute of Health In patients with bladder cancer, chemotherapy effectiveness is partially determined by the body’s immune system response to the malignancy.…

News | 03 November 2020

On November 1, 2020, Professor Georg Duda took up the tenured W3 Professorship for Engineering Regenerative Therapies at the Berlin Institute of Health (BIH) and at Charité – Universitätsmedizin…